-->

The New January Products

New products

What’s new in the PerkinElmer reagent portfolio ?

New products using the HTRF® technology

The Biomarkers assays portfolio is enriched with 5 new kits !

In addition, 2 assays have been added to the Cellular Phospho-Protein assays portfolio and 2 other assays to the Protein-Protein Interactions assays portfolio !

Targeted Protein Degradation portfolio has been enriched with two new kits:

New products using the AlphaLISA® technology

In the Biomarkers assays portfolio:

The Protein-Protein Interactions assays portfolio have been enriched with two forms of an attractive target in cancer therapies: the X-linked inhibitor of apoptosis protein.

The complement factor C1Q is now available in the innate immunity portfolio:

New products using the AlphaLISA® SureFire® Ultra™ technology

And, finally, 9 new assays were added to the Cellular Phospho-Protein assays portfolio !

For all the Alpha® products, please contact your local representatives or visit www.perkinelmer.com